TUESDAY, Oct. 3, 2023 (HealthDay News) — Drinking dark tea daily may help balance blood sugar levels and stave off type 2 diabetes, the form of the disease most closely tied to obesity. This is the main message from a new study that looked at tea-drinking habits and diabetes riskContinue Reading
MONDAY, Oct. 2, 2023 (HealthDay News) — Diabetes may accelerate the growth of a blood cancer known as multiple myeloma, affecting overall survival, according to a new study. The research, published Sept. 29 in the journal Blood Advances, also underscores differences in survival outcomes for Black patients versus white patientsContinue Reading
THURSDAY, Sept. 28, 2023 (HealthDay News) — Type 1 diabetes has long been viewed as a childhood disease, but a new study suggests it might be time to revise that thinking. Investigators concluded that nearly 4 in 10 Americans with type 1 diabetes aren’t diagnosed with the blood sugar conditionContinue Reading
WEDNESDAY, Sept. 27, 2023 (HealthDay News) — Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines. The U.S. Food and Drug Administration recently made the label update for the drug made byContinue Reading
MONDAY, Sept. 25, 2023 (HealthDay News) — For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes seriously high blood sugar levels. “This is a very effective drug that we should be using to treat breast cancer,Continue Reading
MONDAY, Sept. 25, 2023 (HealthDay News) — One day, it may be possible to monitor people for risk of disease through continuously measuring skin temperature. Researchers have found in a new study that wrist temperature is associated with future risk of disease. “These findings indicate the potential to marry emergingContinue Reading
FRIDAY, Sept. 22, 2023 (HealthDay News) – New research suggests some newer diabetes treatments may not be as beneficial for Black patients, after earlier drug trials included small numbers of non-white people. Whether the medications — called sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) and glucogen-like peptide 1 receptor agonists (GLP1-Ras) —Continue Reading
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — Another diabetes drug maker is taking legal action against businesses in several states, alleging that they’re “fraudulently claiming” that their compounded products are the same as its medication. This time, it’s Eli Lilly suing certain medical spas, wellness centers and compounding pharmacies overContinue Reading
MONDAY, Sept. 18, 2023 (HealthDay News) — Low-carb diets may be all the rage, but they’re not for kids with diabetes, according to the American Academy of Pediatrics (AAP). In a new report, the AAP says that low-carbohydrate diets cannot be recommended for children or teenagers with either type 1Continue Reading
TUESDAY, Sept. 12, 2023 (HealthDay News) — Staying up late comes naturally to some folks, whether they’re working or relaxing deep into the night. But being a night owl might come at a cost to one’s health. People who are night owls have a higher risk than early birds ofContinue Reading